Oncology and Pharmaceutical Medication Supply for Indian Army

This tender, with Bid Number GEM/2026/B/8097412, is issued by the Department of Military Affairs, under the Ministry of Defence, on behalf of the Indian Army. The tender is for the supply of a comprehensive range of critical pharmaceutical medications. Specifically, the tender encompasses Axitinib 5 mg tablets, Bicalutamide 50 mg tablets, Capecitabine 500 mg tablets, Imatinib Mesylate 100 mg tablets, Injection Triptorelin 22.5 mg, Nintedanib 150 mg capsules, Sorafenib 200 mg tablets, Temozolomide 250 mg capsules, Cap Tegonat 20 mg (containing Tegafur 20mg, Gimeracil 5.8mg, and Oteracil 15.8mg), Dacomitinib 15 mg tablets, Bosutinib 100 mg tablets, Midostaurin 25 mg tablets, Relugolix 120 mg tablets, and Crizotinib 250 mg tablets. The total quantity required across all listed items is 11,104 units. The bidding period commences on 30-09-2026 at 8:30 AM and concludes on 10-10-2026 at 9:00 AM. This opportunity is for potential suppliers to provide essential medicines to the esteemed Indian Army.